BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1303096)

  • 1. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties.
    Wilbanks GA; Streilein JW
    Reg Immunol; 1992; 4(3):130-7. PubMed ID: 1303096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
    Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
    J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
    Wilbanks GA; Streilein JW
    Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
    Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
    Kawashima H; Yamagami S; Tsuru T; Gregerson DS
    Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells.
    Okamoto S; Hara Y; Streilein JW
    Transplantation; 1995 Feb; 59(3):377-81. PubMed ID: 7871568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen.
    Ferguson TA; Herndon JM
    Invest Ophthalmol Vis Sci; 1994 Jun; 35(7):3085-93. PubMed ID: 8206727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.
    Ferguson TA; Herndon JM; Dube P
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2643-51. PubMed ID: 8163352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior chamber-associated immune deviation induced by soluble antigens.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
    Chattopadhyay S; O'Rourke J; Cone RE
    Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
    Wang Y; O'Rourke J; Cone RE
    Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior chamber associated immune deviation induced by TNP-splenocytes (TNP-ACAID). I. Systemic tolerance mediated by suppressor T-cells.
    Waldrep JC; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1086-92. PubMed ID: 6192107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal anterior chamber associated immune deviation (ACAID) in 129-strain mice.
    Herndon J; Gibler TS; Ferguson TA; Van Gelder RN
    Ocul Immunol Inflamm; 2006 Feb; 14(1):7-12. PubMed ID: 16507485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.